Found: 2
Select item for more details and to access through your institution.
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 5, p. 1498, doi. 10.1093/infdis/jiad441
- By:
- Publication type:
- Article
Identification of immunodominant T cell epitopes induced by natural Zika virus infection.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1247876
- By:
- Publication type:
- Article